Last reviewed · How we verify

NCT03331159

Evaluation of Fusion After ALIF With an Osteoinductive Material or With Homologus Bone

Completed NA Last updated 6 November 2017
What this trial tests

NA trial testing NanoBone in Fusion of Spine, Lumbar Region in 20 participants. Completed in 31 October 2015.

Timeline
1 July 2012
Primary endpoint
31 October 2013
31 October 2015

Quick facts

Lead sponsorJohann Wolfgang Goethe University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment20
Start date1 July 2012
Primary completion31 October 2013
Estimated completion31 October 2015

Drugs / interventions tested

Conditions studied

Sponsor

Johann Wolfgang Goethe University Hospital

Who can join

18 and older, any sex, with Fusion of Spine, Lumbar Region. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to determine whether instrumented anterior lumbar interbody Fusion with a new nanocrystalline hydroxyapatite embedded in a silica gel matrix (NH-SiO2) was associated with superior radiological and clinical outcomes at 12 months follow-up compared with instrumented ALIF with homologous bone

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Precision medicine strategies for spinal degenerative diseases: Injectable biomaterials with in situ repair and regeneration.
    Zhao X, Ma H, Han H, Zhang L, et al · · 2022 · cited 22× · PMID 35799898 · DOI 10.1016/j.mtbio.2022.100336

Verify or expand the search:

Other trials of NanoBone

Trials testing the same drug.

Other recruiting trials for Fusion of Spine, Lumbar Region

Currently open trials in the same condition.

Other Johann Wolfgang Goethe University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03331159.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing